We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PLRX icon
401
Pliant Therapeutics
PLRX
$53.2M
$53.2M $0.8589 0.13%
XLO icon
402
Xilio Therapeutics
XLO
$52.8M
$52.8M $8.03 3.35%
HRTX icon
403
Heron Therapeutics
HRTX
$52.7M
$52.7M $0.2777 5.67%
CNTB icon
404
Connect Biopharma Holdings
CNTB
$50.5M
$50.5M $0.8022 3.97%
IBIO icon
405
iBio
IBIO
$49.4M
$49.4M $0.7687 5.52%
GANX icon
406
Gain Therapeutics
GANX
$49.3M
$49.3M $1.13 5.04%
HYPD icon
407
Hyperion DeFi Inc
HYPD
$49M
$49M $3.22 8.26%
KLRS icon
408
Kalaris Therapeutics
KLRS
$48.3M
$48.3M $2.03 4.69%
ANVS icon
409
Annovis Bio
ANVS
$48.2M
$48.2M $1.13 10.8%
HOWL icon
410
Werewolf Therapeutics
HOWL
$47.9M
$47.9M $0.9861 10.4%
LONA icon
411
LeonaBio Inc
LONA
$46.5M
$46.5M $4.94 0.61%
IMA icon
412
ImageneBio Inc
IMA
$46.5M
$46.5M $4.10 1.23%
BMEA icon
413
Biomea Fusion
BMEA
$46.4M
$46.4M $0.6395 2.68%
MREO icon
414
Mereo BioPharma
MREO
$46.2M
$46.2M $0.2895 4.08%
TIL icon
415
Instil Bio
TIL
$46.1M
$46.1M $6.80 0.44%
ELTX icon
416
Elicio Therapeutics
ELTX
$45.5M
$45.5M $1.68 4%
CRBU icon
417
Caribou Biosciences
CRBU
$45.4M
$45.4M $0.4232 4.9%
INMB icon
418
INmune Bio
INMB
$44.9M
$44.9M $1.45 9.38%
GRDX icon
419
GridAI Technologies Corp
GRDX
$44.1M
$44.1M $4.96 8.99%
DWTX icon
420
Dogwood Therapeutics
DWTX
$43.5M
$43.5M $1.28 4.07%
ATHE icon
421
Alterity Therapeutics
ATHE
$41.2M
$41.2M $2.16 3.14%
GRCE icon
422
Grace Therapeutics
GRCE
$40.8M
$40.8M $1.94 0%
EXOZ icon
423
eXoZymes Inc
EXOZ
$38.4M
$38.4M $4.13 0.49%
VERU icon
424
Veru
VERU
$37.3M
$37.3M $2.19 1.79%
LITS icon
425
Lite Strategy Inc
LITS
$34.1M
$34.1M $1.12 4.27%
15 16
17
18 19

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.